AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
These Stocks Are Moving the Most Today: Cleveland-Cliffs, Steel Dynamics, Tesla, NIO, Blueprint Medicines, Moderna, and More
Shares of steel companies soar after President Donald Trump says he will raise tariffs on imported steel to 50% from 25%. Continue Reading View Comments
- June 02, 2025 04:11 AM PDT
- EODHD
India’s Maruti Suzuki sees no immediate impact from China rare earth magnet ban
India’s leading car manufacturer, Maruti Suzuki, stated on Monday that the recent export restrictions imposed by China on rare earth magnets, a crucial component in their vehicles, have not yet caused any immediate disruption to their production.  The company also mentioned that they are currently engaging in discussions with the government regarding this issue, according […]
- June 02, 2025 04:05 AM PDT
- Invezz
Science Applications Non-GAAP EPS of $1.92 misses by $0.20, revenue of $1.88B beats by $10M
* Science Applications press release [https://seekingalpha.com/pr/20122279-saic-announces-first-quarter-of-fiscal-year-2026-results] (NASDAQ:SAIC [https://seekingalpha.com/symbol/SAIC]): Q1 Non-GAAP E...
- June 02, 2025 04:02 AM PDT
- EODHD
AstraZeneca Says DATROWAY Shows Promising Results in Combination Trials for Lung Cancer
AstraZeneca (AZN) said Sunday that DATROWAY, a TROP2-directed antibody drug conjugate, showed promis PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscripti...
- June 02, 2025 04:01 AM PDT
- EODHD
Jade Biosciences to Present New Preclinical Data on JADE101 at the 62nd European Renal Association Congress
SAN FRANCISCO and VANCOUVER, British Columbia, June 02, 2025 (GLOBE NEWSWIRE) -- Jade Biosciences, Inc. (“Jade”) (Nasdaq: JBIO), a biotechnology company focused on developing best-in-class therapies f...
- June 02, 2025 04:00 AM PDT
- EODHD
Sanofi Exercises License Extension Option to Nurix’s STAT6 Program
STAT6 is a key transcription factor within the IL4/IL13 signaling pathways which act as drivers of inflammation in allergic conditions Nurix to receive a $15 million license extension fee from Sanofi...
- June 02, 2025 04:00 AM PDT
- EODHD
Instil Bio Announces Appointment of Jamie Freedman, M.D., Ph.D., as Chief Medical Officer
DALLAS, June 02, 2025 (GLOBE NEWSWIRE) -- Instil Bio, Inc. (“Instil”) (Nasdaq: TIL), a clinical-stage biopharmaceutical company focused on developing a pipeline of novel cancer therapies, today announ...
- June 02, 2025 04:00 AM PDT
- EODHD
JetBlue not pursuing merger with United Airlines, says CEO
NEW DELHI (Reuters) - JetBlue Airways CEO Joanna Geraghty said on Monday the company's partnership with United Airlines would not lead to a merger between the two carriers. The two companies last week...
- June 02, 2025 03:55 AM PDT
- EODHD
Netskope Taps Morgan Stanley for IPO That Could Raise $500M+
Netskope picked Morgan Stanley (MS, Financials) to lead its U.S. IPO plans, aiming to go public as soon as Q3, Reuters reported, with expectations to raise over $500 million. Warning! GuruFocus has de...
- June 02, 2025 03:53 AM PDT
- EODHD
KKR provides $600M financing to an India's Manipal Group
* KKR (NYSE:KKR [https://seekingalpha.com/symbol/KKR]) announced a $600-million financing arrangement for India's Manipal Education and Medical Group, anchored by KKR’s private credit and insurance pl...
- June 02, 2025 03:46 AM PDT
- EODHD